Saline Placebo

Preclinical

TTLC Biopharmaceuticals, Inc.

Saline Placebo is one of 2 therapeutic programs targeting Carbon Monoxide Poisoning. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Carbon Monoxide PoisoningNot yet recruiting

Carbon Monoxide PoisoningPreclinical

Not yet recruiting

Competition

Competitive Landscape

1 competitor in Carbon Monoxide Poisoning

#DrugCompanyPhaseTrials

Decadron

AAspen Global Incorporated

Preclinical

1 2

Saline Placebo

TTLC Biopharmaceuticals, Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

PreclinicalNot yet recruiting

Carbon Monoxide Poisoning

NCT06574048

Phase 2Recruiting

Trauma

NCT05958342

Q1 2029

Phase 1Not yet recruiting

Asthma (diagnosis)

NCT07600190

Q4 2029

Phase 1Not yet recruiting

Smoking

NCT07771725

Clinical

Trials by Indication[1]

Trauma1 trial

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Recruiting·JJason Sperry·Phase 2·NCT05958342·1,050 enrolled

Smoking1 trial

Impact of Sweeteners on the Addictive Threshold of Nicotine

Not yet recruiting·YYale University·Phase 1·NCT07771725·36 enrolled

Carbon Monoxide Poisoning1 trial

Trial of Dexamethasone vs Placebo as an Adjunctive Therapy to Hyperbaric Oxygen Treatment HBO in Patients With Acute Carbon Monoxide Poisoning

Not yet recruiting·UUniversity of Nebraska·Preclinical·NCT06574048·20 enrolled

Asthma (Diagnosis)1 trial

Anakinra Rescue Treatment for Moderate Asthma Attacks (ARTMA) Pilot Study

Not yet recruiting·UUniversity of North Carolina, Chapel Hill·Phase 1·NCT07600190·60 enrolled

Post Operative Pain1 trial

A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

Active, not recruiting·TTLC Biopharmaceuticals, Inc.·Phase 3·NCT07222748·304 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Saline Placebo. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Saline Placebo. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — TLC Biopharmaceuticals, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: TTLC Biopharmaceuticals, Inc.

Saline Placebo

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q1 2028

Q1 2029

Q4 2029

Trials by Indication[1]

Trauma1 trial

Smoking1 trial

Carbon Monoxide Poisoning1 trial

Asthma (Diagnosis)1 trial

Post Operative Pain1 trial

References

Drug Info

Quick Facts

Related News